Comments
Loading...
Sensus Healthcare Analyst Ratings and Price Targets | NASDAQ:SRTS | Benzinga
Sensus Healthcare Inc has a consensus price target of $11.5 based on the ratings of 4 analysts. The high is $14 issued by Maxim Group on November 15, 2024. The low is $7 issued by Alliance Global Partners on May 4, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Lake Street, and HC Wainwright & Co. on April 4, 2025, March 11, 2025, and February 10, 2025, respectively. With an average price target of $12.33 between HC Wainwright & Co., Lake Street, and HC Wainwright & Co., there's an implied 182.87% upside for Sensus Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Lake Street
Maxim Group
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for Sensus Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/04/2025 | Buy Now | 175.23% | HC Wainwright & Co. | Yi Chen57% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/11/2025 | Buy Now | 198.17% | Lake Street | Ben Haynor37% | $18 → $13 | Maintains | Buy | Get Alert |
| 02/10/2025 | Buy Now | 175.23% | HC Wainwright & Co. | Yi Chen57% | $11 → $12 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 152.29% | HC Wainwright & Co. | Yi Chen57% | $10 → $11 | Maintains | Buy | Get Alert |
| 11/15/2024 | Buy Now | 221.1% | Maxim Group | Anthony Vendetti63% | $12 → $14 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | 129.36% | HC Wainwright & Co. | Yi Chen57% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 129.36% | HC Wainwright & Co. | Yi Chen57% | $8 → $10 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 129.36% | Maxim Group | Anthony Vendetti63% | $7 → $10 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 83.49% | HC Wainwright & Co. | Yi Chen57% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2023 | Buy Now | 83.49% | HC Wainwright & Co. | Yi Chen57% | $10 → $8 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 129.36% | HC Wainwright & Co. | Yi Chen57% | $16 → $10 | Reiterates | → Buy | Get Alert |
| 05/04/2023 | Buy Now | 60.55% | Alliance Global Partners | Ben Haynor37% | $14.5 → $7 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 266.97% | HC Wainwright & Co. | Yi Chen57% | → $16 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 232.57% | Alliance Global Partners | Ben Haynor37% | $16.5 → $14.5 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 278.44% | Alliance Global Partners | Ben Haynor37% | $17.5 → $16.5 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | 266.97% | HC Wainwright & Co. | Yi Chen57% | $13 → $16 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Sensus Healthcare (SRTS) stock?
The latest price target for Sensus Healthcare (NASDAQ:SRTS) was reported by HC Wainwright & Co. on April 4, 2025. The analyst firm set a price target for $12.00 expecting SRTS to rise to within 12 months (a possible 175.23% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
The latest analyst rating for Sensus Healthcare (NASDAQ:SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare reiterated their buy rating.
When was the last upgrade for Sensus Healthcare (SRTS)?
There is no last upgrade for Sensus Healthcare
When was the last downgrade for Sensus Healthcare (SRTS)?
There is no last downgrade for Sensus Healthcare.
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on April 4, 2025 so you should expect the next rating to be made available sometime around April 4, 2026.
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a reiterated with a price target of $12.00 to $12.00. The current price Sensus Healthcare (SRTS) is trading at is $4.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
